Patients with high peritumoral VEGFR-2 expression had a markedly lower MVD in the tumor tissue (3.08%±0.20% vs. low peritumoral VEGFR-2: 8.39%±0.45%; p = 0.002) and in the peritumoral tissue (0.67%±0.03% vs. low peritumoral VEGFR-2: 3.25%±0.02%; p = 0.005). The gene discussed is KDR; the disease is neoplasm.